Intra-S-phase checkpoint activation by direct CDK2 inhibition

Molecular and Cellular Biology
Yonghong ZhuEmma Lees

Abstract

To ensure proper progression through a cell cycle, checkpoints have evolved to play a surveillance role in maintaining genomic integrity. In this study, we demonstrate that loss of CDK2 activity activates an intra-S-phase checkpoint. CDK2 inhibition triggers a p53-p21 response via ATM- and ATR-dependent p53 phosphorylation at serine 15. Phosphorylation of other ATM and ATR downstream substrates, such as H2AX, NBS1, CHK1, and CHK2 is also increased. We show that during S phase when CDK2 activity is inhibited, there is an unexpected loading of the minichromosome maintenance complex onto chromatin. In addition, there is an increased number of cells with more than 4N DNA content, detected in the absence of p53, suggesting that rereplication can occur as a result of CDK2 disruption. Our findings identify an important role for CDK2 in the maintenance of genomic stability, acting via an ATM- and ATR-dependent pathway.

References

Nov 18, 1992·Journal of the National Cancer Institute·G KaurE Sausville
Sep 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·T AkiyamaK Toyoshima
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J A PietenpolB Vogelstein
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Feb 3, 1998·Molecular and Cellular Biology·J S Lanni, T Jacks
Apr 16, 1998·The Journal of Biological Chemistry·E P RogakouW M Bonner
Jan 30, 1999·Genes & Development·R S TibbettsR T Abraham
Oct 26, 1999·Current Biology : CB·A BlasinaC H McGowan
Nov 13, 1999·Nature Cell Biology·J Pines
Apr 5, 2000·The Journal of Biological Chemistry·Y IshimiM Kitagawa
Apr 27, 2000·The Journal of Biological Chemistry·Q B SheZ Dong
Dec 1, 2000·Nature·B VogelsteinA J Levine
Dec 2, 2000·Nature·B B Zhou, S J Elledge
Jan 4, 2001·Current Biology : CB·N Rhind, P Russell
Jul 17, 2001·The Journal of Biological Chemistry·Y Ishimi, Y Komamura-Kohno
Aug 11, 2001·Physical Review Letters·Q R AhmadUNKNOWN SNO Collaboration. Sudbury Neutrino Observatory
Sep 7, 2001·Genes & Development·R T Abraham
Sep 13, 2001·Current Biology : CB·E H Hinchcliffe, G Sluder
Sep 26, 2001·The Journal of Biological Chemistry·S BurmaD J Chen
Oct 24, 2001·The Journal of Biological Chemistry·I M Ward, J Chen
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Ian R HardcastleRoger J Griffin
Feb 19, 2002·Trends in Cell Biology·J Julian Blow, Ben Hodgson
Feb 28, 2002·Molecular and Cellular Biology·Ivailo S MihaylovHui Zhang
Mar 14, 2002·Current Opinion in Cell Biology·Justine Melo, David Toczyski
May 4, 2002·Nature Reviews. Molecular Cell Biology·Damien D'Amours, Stephen P Jackson
Jun 25, 2002·Nature Cell Biology·Dawn CoverleyRonald A Laskey
Jan 16, 2003·Cell·Anne M CasperThomas W Glover
Jan 31, 2003·Nature·Christopher J Bakkenist, Michael B Kastan
Mar 4, 2003·Nature Reviews. Cancer·Yosef Shiloh
Mar 12, 2003·Trends in Cell Biology·Cristina Pelizon
Apr 5, 2003·Cancer Cell·Osamu Tetsu, Frank McCormick
Apr 30, 2003·Molecular Cell·Cyrus VaziriAnindya Dutta

❮ Previous
Next ❯

Citations

Sep 29, 2011·Molecular and Cellular Biology·Bing SongXiaoqi Liu
Jul 19, 2005·Molecular and Cellular Biology·Vincent ArchambaultFrederick R Cross
Jan 15, 2014·PLoS Pathogens·Richard O Adeyemi, David J Pintel
Dec 29, 2010·Indian Journal of Pharmaceutical Sciences·M P Suthar, M M Patel
Nov 19, 2013·Apoptosis : an International Journal on Programmed Cell Death·Sujoy BhattacharyaLeonard R Johnson
Aug 11, 2010·The Journal of Cell Biology·Addolorata PiscontiBradley B Olwin
Jan 1, 2008·Expert Opinion on Drug Discovery·Robert C JacksonSimon R Green
May 11, 2005·Expert Opinion on Investigational Drugs·Peter M Fischer, Athos Gianella-Borradori
May 8, 2013·Expert Opinion on Investigational Drugs·Prithviraj BoseSteven Grant
Nov 13, 2012·FEBS Letters·Anamika DhyaniSara T Olalla Saad
Jan 18, 2006·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Tetsuya TsukamotoMasae Tatematsu
Dec 2, 2014·Radiology and Oncology·Friedo ZölzerChristian Streffer
Jun 3, 2006·Journal of Cellular Physiology·Luciana E Giono, James J Manfredi
May 31, 2019·BMC Bioinformatics·Maryam Masnadi-ShiraziShankar Subramaniam
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Claudia E RübeChristian Rübe
Apr 19, 2006·Cancer Research·Marc PaytonSteve Coats
Nov 21, 2007·Molecular Cancer Research : MCR·Chit Fang CheokDavid P Lane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.